STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
STAT [Unofficial]
April 28, 2026
Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news today
Discussion in the ATmosphere